Mortality by causes in HIV-infected adults: comparison with the general population
Open Access
- 11 May 2011
- journal article
- research article
- Published by Springer Nature in BMC Public Health
- Vol. 11 (1) , 300
- https://doi.org/10.1186/1471-2458-11-300
Abstract
Background: We compared mortality by cause of death in HIV-infected adults in the era of combined antiretroviral therapy with mortality in the general population in the same age and sex groups. Methods: Mortality by cause of death was analyzed for the period 1999-2006 in the cohort of persons aged 20-59 years diagnosed with HIV infection and residing in Navarre (Spain). This was compared with mortality from the same causes in the general population of the same age and sex using standardized mortality ratios (SMR). Results: There were 210 deaths among 1145 persons diagnosed with HIV (29.5 per 1000 person-years). About 50% of these deaths were from AIDS. Persons diagnosed with HIV infection had exceeded all-cause mortality (SMR 14.0, 95% CI 12.2 to 16.1) and non-AIDS mortality (SMR 6.9, 5.7 to 8.5). The analysis showed excess mortality from hepatic disease (SMR 69.0, 48.1 to 78.6), drug overdose or addiction (SMR 46.0, 29.2 to 69.0), suicide (SMR 9.6, 3.8 to 19.7), cancer (SMR 3.2, 1.8 to 5.1) and cardiovascular disease (SMR 3.1, 1.3 to 6.1). Mortality in HIV-infected intravenous drug users did not change significantly between the periods 1999-2002 and 2003-2006, but it declined by 56% in non-injecting drug users (P = 0.007). Conclusions: Persons with HIV infection continue to have considerable excess mortality despite the availability of effective antiretroviral treatments. However, excess mortality in the HIV patients has declined since these treatments were introduced, especially in persons without a history of intravenous drug use.Keywords
This publication has 34 references indexed in Scilit:
- Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIVAIDS, 2010
- Suicide in HIV-Infected Individuals and the General Population in Switzerland, 1988–2008American Journal of Psychiatry, 2010
- Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countriesInternational Journal of Epidemiology, 2009
- Causes of death in HIV-infected women: persistent role of AIDS. The 'Mortalite 2000 & 2005' Surveys (ANRS EN19)International Journal of Epidemiology, 2009
- HIV type 1 infection, and not short-term HAART, induces endothelial dysfunctionAIDS, 2009
- Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort studyAIDS, 2009
- Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factorsAIDS, 2008
- Changes in the Risk of Death After HIV Seroconversion Compared With Mortality in the General PopulationJAMA, 2008
- Clinical progression of hepatitis C virus–related chronic liver disease in human immunodeficiency virus–infected patients undergoing highly active antiretroviral therapyHepatology, 2007
- Evaluación del sistema de información de Navarra sobre diagnósticos de infección por el VIH, 1985-2003Revista Espanola de Salud Publica, 2007